MedTrace Logo

Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow

NCT01637662 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2015-07-29

No results posted yet for this study

Summary

To investigate headache score and accompanying symptoms during and after infusion of the natriuretic peptides.

Conditions

Interventions

DRUG

Natriuretic peptides

I.V. infusion between 0.2-3 microgram over 20 minutes

Sponsors & Collaborators

  • Danish Headache Center

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2014-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01637662 on ClinicalTrials.gov